Coronary sinus reducer for the treatment of refractory angina (ORBITA-COSMIC): a randomised, placebo-controlled trialMichael Foley, Rasha Al‐Lamee, Shayna Chotai et al.|The Lancet|2024Cited by 86
Symptoms as a Predictor of the Placebo-Controlled Efficacy of PCI in Stable Coronary Artery DiseaseFlorentina Simader, Amit Kaura, Christopher Rajkumar et al.|Journal of the American College of Cardiology|2024Cited by 36